Antiproliferative and GH-Inhibitory Activity of Chimeric Peptides Consisting of GHRP-6 and Somatostatin
- 7 June 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 259 (2) , 379-384
- https://doi.org/10.1006/bbrc.1999.0773
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Growth Hormone-Releasing Peptides and Their AnalogsFrontiers in Neuroendocrinology, 1998
- Somatostatin ReceptorsTrends in Endocrinology & Metabolism, 1997
- Interaction of the growth hormone releasing peptide hexarelin with somatostatinClinical Endocrinology, 1997
- Somatostatin: the neuroendocrine storyTrends in Pharmacological Sciences, 1997
- A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone ReleaseScience, 1996
- Somatostatin analog RC‐160 inhibits growth of CFPAC‐1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphateInternational Journal of Cancer, 1995
- Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.Endocrinology, 1994
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990
- Implications of the X-ray structure of deamino-oxytocin to agonist/antagonist-receptor interactionsTrends in Pharmacological Sciences, 1987
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982